Successful Reduced-Intensity Stem Cell Transplantation from an HLA Haploidentical 3-Loci-Mismatched Donor on the Basis of Fetomaternal Microchimerism in a Patient with Advanced Acute Myeloid Leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-07-01
著者
-
Uoshima Nobuhiko
京都府立医科大学 血液・腫瘍内科学
-
Uoshima Nobuhiko
Department Of Hematology Matsushita Memorial Hospital
-
Uoshima Nobuhiko
Department Of Internal Medicine Matsushima Memorial Hospital
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Saji Hiroh
東海大学 医学部小児科学
-
Saji H
Npohla Lab. Kyoto Jpn
-
Saji Hiroh
Hla Laboratory
-
Maruya Etsuko
東海大学 医学部小児科学
-
Maruya E
Npohla Lab. Kyoto Jpn
-
Maruya Etsuko
Hla Laboratory
-
KAMITSUJI Yuri
Department of Internal Medicine, Matsushima Memorial Hospital
-
Kamitsuji Yuri
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Kamitsuji Yuri
Department Of Internal Medicine Matsushima Memorial Hospital
-
Kamitsuji Yuri
Department Of Hematology Matsushita Memorial Hospital
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Outcome of Non-T-Cell-Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation from Family Donors in Children and Adolescents
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Second Transplantation from HLA 2-Loci-Mismatched Mother for Graft Failure Due to Hemophagocytic Syndrome after Cord Blood Transplantation
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
- Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
- Power of association test for detecting minor histocompatibility gene causing graft-versus-host disease following bone barrow transplantation
- Successful Reduced-Intensity Stem Cell Transplantation from an HLA Haploidentical 3-Loci-Mismatched Donor on the Basis of Fetomaternal Microchimerism in a Patient with Advanced Acute Myeloid Leukemia
- Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Rescued with a Second Allogeneic Stem Cell Transplantation from a Haploidentical Mother after Relapse following Cord Blood Transplantation
- Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
- Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients
- Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
- Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
- CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
- Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli
- Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
- Successful Immunosuppressive Therapy with Cyclosporine A for Posthepatitis B-Cell Deficiency With Activated Cytoplasmic Interferon-γ-Positive T-Lymphocytes
- Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype : a study by the Japanese Childhood AML Cooperative Study Group
- Renal vein lymphoma embolism in non-Hodgkin lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Two Cases of Mediastinal Gray Zone Lymphoma
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
- The Response to Second-line Induction with Bortezomib and Dexamethasone is Predictive of Long-term Outcomes Prior to High-dose Chemotherapy with Autologous Stem Cell Transplantation for Multiple Myeloma